24.39
24.39 (0%)
As of Feb 14, 2025
Structure Therapeutics Inc. [GPCR]
Source:
Company Overview
Structure Therapeutics Inc. is a clinical stage global biopharmaceutical company developing novel oral small molecule therapeutics to treat a wide range of chronic diseases with unmet medical need.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | (650) 457-1978 |
| Industry | manufacturing |
| CEO | Raymond Stevens |
| Website | www.structuretx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-158.2 |
| Net Income | $-122.5 |
| Net Cash | $39.7 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -17.7% |
| Profit as % of Stockholder Equity | -14.2% |
Management Effectiveness
| Return on Equity | -14.2% |
| Return on Assets | -13.6% |
| Turnover Ratio | |
| EBITA | $-158.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $903.3 |
| Total Liabilities | $38.5 |
| Operating Cash Flow | $-116.6 |
| Investing Cash Flow | $-358.9 |
| Financing Cash Flow | $515.3 |
